It is also worth to underline that targeting mTOR cascade alone may have limited therapeutic efficacy because tumor cell proliferation could be fully sustained via the compensatory activation of the Ras/MAPK cascade [35,36]. This evidence concerns the gene MTOR and neoplasm.